Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
522.40M | 593.71M | 901.71M | 556.24M | 351.32M | Gross Profit |
47.80M | 86.26M | 348.37M | 138.98M | 17.05M | EBIT |
-5.50M | 51.78M | 308.38M | 28.68M | -15.54M | EBITDA |
82.69M | 120.70M | 378.60M | 170.99M | 55.31M | Net Income Common Stockholders |
-19.35M | 27.92M | 230.35M | 43.55M | -61.91M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
184.20M | 305.93M | 394.32M | 82.14M | 16.26M | Total Assets |
1.19B | 1.30B | 1.44B | 1.13B | 1.05B | Total Debt |
30.50M | 619.99M | 743.28M | 559.93M | 517.61M | Net Debt |
10.27M | 521.49M | 679.52M | 477.78M | 501.35M | Total Liabilities |
465.83M | 779.85M | 923.95M | 672.35M | 631.56M | Stockholders Equity |
721.36M | 518.33M | 515.87M | 460.49M | 421.74M |
Cash Flow | Free Cash Flow | |||
86.58M | 69.92M | 299.82M | 52.50M | -32.98M | Operating Cash Flow |
86.58M | 137.52M | 345.65M | 87.63M | -2.51M | Investing Cash Flow |
-53.08M | 57.40M | -369.74M | -34.69M | -28.43M | Financing Cash Flow |
-114.30M | -157.66M | 5.71M | 12.95M | 24.41M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $13.74B | 12.02 | 24.43% | 2.56% | -10.48% | -13.78% | |
68 Neutral | $822.21M | 13.50 | 15.06% | 8.96% | -22.91% | -64.68% | |
63 Neutral | $7.33B | 42.32 | 1.52% | 3.60% | -18.79% | -84.24% | |
55 Neutral | $7.16B | 507.35 | 0.20% | 1.14% | -10.25% | -70.81% | |
54 Neutral | $482.11M | ― | -2.68% | ― | -12.01% | -174.13% | |
54 Neutral | $319.17M | ― | -44.87% | ― | -8.74% | -492.08% | |
47 Neutral | $2.64B | -4.00 | -31.55% | 3.33% | 2.93% | -29.90% |
On February 27, 2025, LSB Industries released its financial results for Q4 and the full year ending December 31, 2024. The company reported increased sales volumes of nitric acid and ammonium nitrate, supported by favorable nitrogen demand and pricing. The company also completed a turnaround of its Cherokee ammonia plant without injuries, and its low carbon ammonia projects are progressing. The stockholder rights plan remains in place to protect net operating losses, and the company has a solid balance sheet with a focus on capital allocation.